• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development and validation of prognostic m6A-related lncRNA and mRNA model in thyroid cancer.甲状腺癌中预后性m6A相关lncRNA和mRNA模型的开发与验证
Am J Cancer Res. 2022 Jul 15;12(7):3259-3279. eCollection 2022.
2
Identification of m6A-related lncRNAs for thyroid cancer recurrence.用于甲状腺癌复发的m6A相关长链非编码RNA的鉴定
Gland Surg. 2023 Jan 1;12(1):39-53. doi: 10.21037/gs-22-678. Epub 2023 Jan 6.
3
Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.胃癌中 m6A 相关 lncRNAs 的肿瘤免疫微环境综合分析与预后评估。
BMC Cancer. 2022 Mar 24;22(1):316. doi: 10.1186/s12885-022-09377-8.
4
Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.鉴定 m6A 相关的长链非编码 RNA 作为甲状腺癌免疫浸润和预后的预测因子。
Ann Med. 2023 Dec;55(1):1298-1316. doi: 10.1080/07853890.2023.2192049.
5
Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.N6-甲基腺嘌呤相关长链非编码RNA在早期结直肠癌中的预后价值:与免疫细胞浸润及化疗药物敏感性的关联
Front Mol Biosci. 2021 Oct 12;8:724889. doi: 10.3389/fmolb.2021.724889. eCollection 2021.
6
An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.一种有效的 N6-甲基腺苷相关长非编码 RNA 预后标志物,用于预测膀胱癌患者的预后。
BMC Cancer. 2021 Nov 21;21(1):1256. doi: 10.1186/s12885-021-08981-4.
7
Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.鉴定和验证一个与 m6A 相关的七个长链非编码 RNA 标志物,用于预测卵巢癌的预后。
BMC Cancer. 2022 Jun 8;22(1):633. doi: 10.1186/s12885-022-09591-4.
8
Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.N6-甲基腺苷相关长非编码 RNA 预后特征综合分析及其与肾透明细胞癌免疫浸润的相关性。
Crit Rev Eukaryot Gene Expr. 2022;32(1):79-98. doi: 10.1615/CritRevEukaryotGeneExpr.2021039325.
9
N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.N6-甲基腺苷相关长非编码 RNA 特征可预测结直肠癌患者的总生存期。
Genes (Basel). 2021 Aug 31;12(9):1375. doi: 10.3390/genes12091375.
10
Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.N6-甲基腺苷相关长链非编码RNA与肺腺癌肿瘤免疫微环境及临床预后的关系
Front Genet. 2021 Oct 20;12:714697. doi: 10.3389/fgene.2021.714697. eCollection 2021.

引用本文的文献

1
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells.m6A甲基化修饰与非编码RNA之间的相互作用及其对肿瘤细胞的影响概述
Transl Cancer Res. 2024 Jun 30;13(6):3106-3125. doi: 10.21037/tcr-23-2401. Epub 2024 Jun 27.
2
Construction of an immune-related prognostic model and potential drugs screening for esophageal cancer based on bioinformatics analyses and network pharmacology.基于生物信息学分析和网络药理学构建食管癌免疫相关预后模型及潜在药物筛选
Immun Inflamm Dis. 2024 May;12(5):e1266. doi: 10.1002/iid3.1266.
3
Prediction of TNFRSF9 expression and molecular pathological features in thyroid cancer using machine learning to construct Pathomics models.使用机器学习构建肿瘤组学模型预测甲状腺癌中 TNFRSF9 的表达和分子病理特征。
Endocrine. 2024 Oct;86(1):324-332. doi: 10.1007/s12020-024-03862-9. Epub 2024 May 16.
4
The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer.N6-甲基腺苷 RNA 修饰在甲状腺癌中的新兴作用。
Eur J Med Res. 2023 Nov 1;28(1):475. doi: 10.1186/s40001-023-01382-2.

本文引用的文献

1
Long non-coding RNA ARHGAP5-AS1 inhibits migration of breast cancer cell via stabilizing SMAD7 protein.长链非编码 RNA ARHGAP5-AS1 通过稳定 SMAD7 蛋白抑制乳腺癌细胞迁移。
Breast Cancer Res Treat. 2021 Oct;189(3):607-619. doi: 10.1007/s10549-021-06286-5. Epub 2021 Aug 9.
2
A Survival-Related Competitive Endogenous RNA Network of Prognostic lncRNAs, miRNAs, and mRNAs in Wilms Tumor.肾母细胞瘤中与生存相关的预后性长链非编码RNA、微小RNA和信使RNA竞争性内源性RNA网络
Front Oncol. 2021 Feb 26;11:608433. doi: 10.3389/fonc.2021.608433. eCollection 2021.
3
LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer.长非编码 RNA 介导的癌症翻译后修饰和能量代谢重编程。
Cancer Commun (Lond). 2021 Feb;41(2):109-120. doi: 10.1002/cac2.12108. Epub 2020 Oct 29.
4
Cancer statistics for adolescents and young adults, 2020.青少年和青年癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Nov;70(6):443-459. doi: 10.3322/caac.21637. Epub 2020 Sep 17.
5
LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5.长链非编码 RNA SLC26A4-AS1 通过使 DDX5 不稳定来抑制 MRN 复合物介导的 DNA 修复信号和甲状腺癌转移。
Oncogene. 2020 Oct;39(43):6664-6676. doi: 10.1038/s41388-020-01460-3. Epub 2020 Sep 16.
6
β-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer.β-catenin 通过抑制 miR455-3p 来刺激 HSF1 mRNA 的 m6A 修饰,从而促进其在结直肠癌中的翻译。
Mol Cancer. 2020 Aug 24;19(1):129. doi: 10.1186/s12943-020-01244-z.
7
Cancer burden of major cancers in China: A need for sustainable actions.中国主要癌症的癌症负担:需要采取可持续行动。
Cancer Commun (Lond). 2020 May;40(5):205-210. doi: 10.1002/cac2.12025. Epub 2020 May 2.
8
The emerging molecular mechanism of mA modulators in tumorigenesis and cancer progression.mA 调节剂在肿瘤发生和癌症进展中的新兴分子机制。
Biomed Pharmacother. 2020 Jul;127:110098. doi: 10.1016/j.biopha.2020.110098. Epub 2020 Apr 13.
9
TNM 8th edition in thyroid cancer staging: is there an improvement in predicting recurrence?第八版甲状腺癌分期中的 TNM 系统:是否能更好地预测复发?
Endocr Relat Cancer. 2020 Jun;27(6):325-336. doi: 10.1530/ERC-19-0412.
10
mA Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.mA 修饰在编码和非编码 RNA 中的作用及其在癌症中的治疗意义。
Cancer Cell. 2020 Mar 16;37(3):270-288. doi: 10.1016/j.ccell.2020.02.004.

甲状腺癌中预后性m6A相关lncRNA和mRNA模型的开发与验证

Development and validation of prognostic m6A-related lncRNA and mRNA model in thyroid cancer.

作者信息

Zhu Yu, Yu Tian, Huang Ju, Ma Xitao, Shen Tao, Li Annuo, Yue Rensong

机构信息

Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075, Sichuan, P. R. China.

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College No. 1 Shuaifuyuan, Wangfujin, Dongcheng District, Beijing 100730, P. R. China.

出版信息

Am J Cancer Res. 2022 Jul 15;12(7):3259-3279. eCollection 2022.

PMID:35968348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9360246/
Abstract

Although N6-methyladenosine (m6A) regulators and lncRNAs influence the carcinogenesis of thyroid cancer (THCA), the association between m6A-related lncRNAs and THCA remains unexplored. Therefore, we have developed and validated a prognostic model based on m6A-related lncRNAs and mRNAs in THCA. Data from the Cancer Genome Atlas were used to analyze the expression and prognostic characteristics of m6A-related lncRNAs and mRNAs in THCA. Univariate Cox regression analysis was used to screen out independent prognostic factors, while Lasso Cox regression was performed to construct m6A-related lncRNA and mRNA models. The correlation between the prognostic models and gene mutation, immune cell infiltration, tumor microenvironment score, tumor mutational burden, and microsatellite instability were assessed. The prognostic models showed excellent accuracy in predicting the prognosis of patients with THCA. Our study established an m6A-related nomogram capable of predicting the prognosis of patients with THCA. In addition, the hub lncRNAs and mRNAs provide insight into improving the prognosis of THCA. These findings can improve our understanding of m6A modifications in THCA and the prognosis and treatment strategies of THCA.

摘要

尽管N6-甲基腺苷(m6A)调节剂和长链非编码RNA(lncRNA)影响甲状腺癌(THCA)的致癌作用,但m6A相关lncRNA与THCA之间的关联仍未得到探索。因此,我们开发并验证了一种基于THCA中m6A相关lncRNA和mRNA的预后模型。来自癌症基因组图谱的数据用于分析THCA中m6A相关lncRNA和mRNA的表达及预后特征。单因素Cox回归分析用于筛选出独立的预后因素,同时进行Lasso Cox回归以构建m6A相关lncRNA和mRNA模型。评估了预后模型与基因突变、免疫细胞浸润、肿瘤微环境评分、肿瘤突变负荷和微卫星不稳定性之间的相关性。预后模型在预测THCA患者的预后方面显示出优异的准确性。我们的研究建立了一种能够预测THCA患者预后的m6A相关列线图。此外,核心lncRNA和mRNA为改善THCA的预后提供了见解。这些发现可以增进我们对THCA中m6A修饰以及THCA的预后和治疗策略的理解。